MEDICLIN Aktiengesellschaft (ETR:MED)

ETR:MED Statistics

Total Valuation

ETR:MED has a market cap or net worth of EUR 171.95 million. The enterprise value is 502.89 million.

Market Cap	171.95M
Enterprise Value	502.89M

Important Dates

The last earnings date was Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

ETR:MED has 47.50 million shares outstanding. The number of shares has decreased by -1.20% in one year.

Current Share Class	47.50M
Shares Outstanding	47.50M
Shares Change (YoY)	-1.20%
Shares Change (QoQ)	-2.55%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	36.39%
Float	11.44M

Valuation Ratios

The trailing PE ratio is 6.70 and the forward PE ratio is 4.96.

PE Ratio	6.70
Forward PE	4.96
PS Ratio	0.21
PB Ratio	0.69
P/TBV Ratio	0.74
P/FCF Ratio	3.18
P/OCF Ratio	1.68
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.35, with an EV/FCF ratio of 9.31.

EV / Earnings	19.73
EV / Sales	0.63
EV / EBITDA	4.35
EV / EBIT	9.08
EV / FCF	9.31

Financial Position

The company has a current ratio of 1.68, with a Debt / Equity ratio of 1.56.

Current Ratio	1.68
Quick Ratio	1.06
Debt / Equity	1.56
Debt / EBITDA	3.37
Debt / FCF	7.22
Interest Coverage	2.51

Financial Efficiency

Return on equity (ROE) is 10.97% and return on invested capital (ROIC) is 7.11%.

Return on Equity (ROE)	10.97%
Return on Assets (ROA)	3.96%
Return on Invested Capital (ROIC)	7.11%
Return on Capital Employed (ROCE)	8.24%
Weighted Average Cost of Capital (WACC)	4.70%
Revenue Per Employee	115,331
Profits Per Employee	3,654
Employee Count	6,974
Asset Turnover	0.92
Inventory Turnover	93.52

Taxes

In the past 12 months, ETR:MED has paid 9.30 million in taxes.

Income Tax	9.30M
Effective Tax Rate	26.41%

Stock Price Statistics

The stock price has increased by +23.13% in the last 52 weeks. The beta is 0.30, so ETR:MED's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	+23.13%
50-Day Moving Average	3.76
200-Day Moving Average	3.39
Relative Strength Index (RSI)	49.27
Average Volume (20 Days)	10,072

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ETR:MED had revenue of EUR 804.32 million and earned 25.49 million in profits. Earnings per share was 0.54.

Revenue	804.32M
Gross Profit	190.96M
Operating Income	55.36M
Pretax Income	35.20M
Net Income	25.49M
EBITDA	115.58M
EBIT	55.36M
Earnings Per Share (EPS)	0.54

Balance Sheet

The company has 72.18 million in cash and 389.72 million in debt, with a net cash position of -317.53 million or -6.68 per share.

Cash & Cash Equivalents	72.18M
Total Debt	389.72M
Net Cash	-317.53M
Net Cash Per Share	-6.68
Equity (Book Value)	249.63M
Book Value Per Share	5.38
Working Capital	114.77M

Cash Flow

In the last 12 months, operating cash flow was 102.44 million and capital expenditures -48.43 million, giving a free cash flow of 54.01 million.

Operating Cash Flow	102.44M
Capital Expenditures	-48.43M
Depreciation & Amortization	60.22M
Net Borrowing	-77.11M
Free Cash Flow	54.01M
FCF Per Share	1.14

Margins

Gross margin is 23.74%, with operating and profit margins of 6.88% and 3.17%.

Gross Margin	23.74%
Operating Margin	6.88%
Pretax Margin	4.38%
Profit Margin	3.17%
EBITDA Margin	14.37%
EBIT Margin	6.88%
FCF Margin	6.72%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 1.10%.

Dividend Per Share	0.04
Dividend Yield	1.10%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	7.45%
Buyback Yield	1.20%
Shareholder Yield	2.30%
Earnings Yield	14.82%
FCF Yield	31.41%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6